FDA Inspection 973194 — Chartwell Pharmaceuticals West Caldwell LLC

Chartwell Pharmaceuticals West Caldwell LLC — FEI 3005376609

The FDA completed an inspection of Chartwell Pharmaceuticals West Caldwell LLC on May 25, 2016 in West Caldwell, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
May 25, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
West Caldwell, NJ (United States)

Additional details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
673021 CFR 314.80(b)Failure to develop written procedures
673221 CFR 314.80(c)(1)(i)Late submission of 15-day report
683321 CFR 314.80(c)(2)(ii)(A)Incomplete periodic safety report

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.